Enas Aljohani

Enas Aljohani holds a Doctor of Philosophy degree from the School of Chemistry, Pharmacy and Pharmacology at the University of East Anglia. Her research focuses on developing novel anticancer agents through organometallic chemistry, particularly ferrocenyl β-diketonate compounds. She has contributed to studies exploring extended ring systems to enhance therapeutic efficacy.

Her work integrates pharmacological principles with medicinal chemistry, aiming to advance cancer therapy. Collaborations with international researchers in related fields have expanded the scope of her projects. Key outputs include peer-reviewed articles on drug design and anticancer mechanisms.

Notable achievements include a 2025 publication in ChemBioChem, which investigates structural modifications for improved therapeutic outcomes. Her research has garnered attention via academic platforms like Mendeley and social media shares on X.